Published in Alcohol Clin Exp Res on November 19, 2008
Matching Genotypes and Serotonergic Medications for Alcoholism | NCT01113164
Medication treatment of different types of alcoholism. Am J Psychiatry (2010) 2.69
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. Am J Psychiatry (2011) 1.69
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmgenomics Pers Med (2012) 1.04
A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav (2012) 0.91
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse. Subst Abuse Rehabil (2012) 0.82
Alcohol addiction: toward a patient-oriented pharmacological treatment. Expert Opin Pharmacother (2013) 0.80
Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study. Alcohol Clin Exp Res (2014) 0.77
Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings. Alcohol (2014) 0.76
Serotonergic gene variation in substance use pharmacotherapy: a systematic review. Pharmacogenomics (2015) 0.76
Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy. Alcohol Alcohol (2015) 0.76
Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol (2017) 0.75
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet (2007) 3.62
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med (2006) 2.55
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Genetic associations with intimate partner violence in a sample of hazardous drinking men in batterer intervention programs. Violence Against Women (2014) 2.31
Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol (2010) 2.27
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98
Association of the serotonin transporter gene promoter region (5-HTTLPR) polymorphism with biased attention for emotional stimuli. J Abnorm Psychol (2009) 1.74
Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet (2003) 1.64
Serotonin transporter genetic variation and biased attention for emotional word stimuli among psychiatric inpatients. J Abnorm Psychol (2007) 1.61
Pharmacotherapy of dual substance abuse and dependence. CNS Drugs (2007) 1.61
Network support as a prognostic indicator of drinking outcomes: the COMBINE Study. J Stud Alcohol Drugs (2010) 1.60
Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature (2005) 1.56
Increased serum high-density lipoprotein-cholesterol concentration in celiac disease after gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol (2009) 1.54
Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol (2009) 1.54
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
Ethanol in formularies of US teaching hospitals. JAMA (2003) 1.44
Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend (2005) 1.43
Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem (2003) 1.42
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol (2010) 1.37
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34
Behavioral economic analysis of cue-elicited craving for alcohol. Addiction (2010) 1.33
Acute alcohol intoxication. Eur J Intern Med (2008) 1.29
Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology (2003) 1.29
Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum (2011) 1.27
The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol (2002) 1.26
The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol (2012) 1.22
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev (2009) 1.16
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2008) 1.15
Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des (2011) 1.13
Effects of craving and DRD4 VNTR genotype on the relative value of alcohol: an initial human laboratory study. Behav Brain Funct (2007) 1.11
Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict Biol (2011) 1.11
Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav (2005) 1.09
Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res (2010) 1.09
Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol Clin Exp Res (2006) 1.09
How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology (2005) 1.08
Acute Effects of Marijuana Smoking on Negative and Positive Affect. J Cogn Psychother (2011) 1.08
Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob Res (2005) 1.08
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol (2007) 1.07
Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2012) 1.06
Homelessness and substance misuse: a tale of two cities. Subst Use Misuse (2003) 1.05
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmgenomics Pers Med (2012) 1.04
Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev (2009) 1.04
Safety and efficacy of baclofen in the treatment of alcohol-dependent patients. Curr Pharm Des (2010) 1.04
Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict (2003) 1.03
Serotonin transporter gene promoter region polymorphism and selective processing of emotional images. Biol Psychol (2009) 1.03
The BDNF Val66Met polymorphism is associated with rumination in healthy adults. Emotion (2009) 1.03
Bitterness of the non-nutritive sweetener acesulfame potassium varies with polymorphisms in TAS2R9 and TAS2R31. Chem Senses (2013) 1.02
Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol (2013) 1.02
Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction (2015) 1.01
Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res (2005) 1.01
Primary angiosarcoma of the kidney: size is the main prognostic factor. Int J Urol (2007) 1.01
Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine Tob Res (2003) 1.00
Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav (2009) 1.00
Estimating pediatric inpatient medication use in the United States. Pharmacoepidemiol Drug Saf (2010) 0.99
Toward an integration of cognitive and genetic models of risk for depression. Cogn Emot (2012) 0.99
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2006) 0.99
Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia. J Immunol (2013) 0.98
Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. J Rheumatol (2012) 0.98
Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav (2010) 0.98
Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives. Alcohol (2009) 0.98
Service to Others in Sobriety (SOS). Alcohol Treat Q (2010) 0.97
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology (2011) 0.97
Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials. Alcohol Alcohol (2013) 0.97
Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature. Digestion (2003) 0.97
Therapygenetics: moving towards personalized psychotherapy treatment. Trends Cogn Sci (2011) 0.97
Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat Behav (2006) 0.96
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. Am J Health Syst Pharm (2004) 0.96
Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken) (2014) 0.95
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics. Exp Clin Psychopharmacol (2007) 0.95
HIV testing in hazardous drinking: a survey analysis. Subst Use Misuse (2010) 0.95
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) (2011) 0.95
Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses. J Immunol (2012) 0.94
Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin Neuropharmacol (2003) 0.94
The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Front Psychiatry (2010) 0.93
Helping Others and Long-term Sobriety: Who Should I Help to Stay Sober? Alcohol Treat Q (2009) 0.93
Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study. Alcohol Clin Exp Res (2008) 0.93
Affective and psychiatric disorders in celiac disease. Dig Dis (2008) 0.93
The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin Investig Drugs (2009) 0.92
Association of the serotonin transporter promoter region polymorphism with biased attention for negative word stimuli. Depress Anxiety (2010) 0.92
A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav (2012) 0.91
Brooding rumination and risk for depressive disorders in children of depressed mothers. J Abnorm Child Psychol (2012) 0.91
Children's 5-HTTLPR genotype moderates the link between maternal criticism and attentional biases specifically for facial displays of anger. Cogn Emot (2011) 0.91
Sex differences in stimulus expectancy and pharmacologic effects of a moderate dose of alcohol on smoking lapse risk in a laboratory analogue study. Psychopharmacology (Berl) (2012) 0.91
Course of functioning 1 year following admission for treatment of alcohol use disorders. Addict Behav (2006) 0.91
New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.91
Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Hum Psychopharmacol (2011) 0.91